The emergence of PD-(L1) treatments has provided patients options where previously none existed, and the leading forms of these therapies have gone on to blockbuster sales.
Although a tone of respectful sobriety lay over the PM Society Awards this year, as the nation’s citizens came from far and wide to London to pay their final respects to Her Majesty Queen Elizabeth
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.